MODULIM
Modulim Click for Video: Clarifi - SFDI Power Value-Based Care CLICK FOR: Quantifying dermal microcirculatory changes of neuropathic and neuroischemic diabetic foot ulcers using spatial frequency domain imaging: a shade of things to come? CLICK FOR: SFDI biomarkers provide a quantitative ulcer risk metric and can be used to predict diabetic foot ulcer onset. CLICK FOR: Near-instant noninvasive optical imaging of tissue perfusion for vascular assessment. CLICK FOR: 0061U Reimbursement Information Sheet CLICK FOR: Clarifi Brochure CLICK FOR: Prevention of Amputation in Veterans Everywhere (PAVE) Flyer Clarifi Imaging System

Modulim

Modulim is a pioneer in subsurface optical imaging powered by spatial frequency domain imaging (SFDI), an advanced optical imaging technique invented by founder and CTO David Cuccia, Ph.D., and his colleagues at UC Irvine’s Beckman Laser Institute in California.

SFDI deciphers the reflection, absorbance, and scattering of light to more accurately measure key indicators of subsurface tissue integrity.

Modulim’s Clarifi® Imaging System is the first non-contact, noninvasive microvascular assessment tool that uses a proprietary optical imaging technique — spatial frequency domain imaging (SFDI) — to provide insight into the delivery and extraction of oxygen to tissue. This information can help clinicians identify patients who are at risk for vascular complications and pinpoint specific areas of potential compromised circulation before the presence of visible symptoms (e.g., ulceration).

CLICK PLAY BUTTON TO WATCH VIDEO

Modulim’s Clarifi® Imaging System is the first non-contact, noninvasive microvascular assessment tool that uses a proprietary optical imaging technique — spatial frequency domain imaging (SFDI) — to provide insight into the delivery and extraction of oxygen to tissue. This information can help clinicians identify patients who are at risk for vascular complications and pinpoint specific areas of potential compromised circulation before the presence of visible symptoms (e.g., ulceration).

CLICK PLAY BUTTON TO WATCH VIDEO

Click for Video: Clarifi - SFDI Power Value-Based Care

CLICK FOR: Quantifying dermal microcirculatory changes of neuropathic and neuroischemic diabetic foot ulcers using spatial frequency domain imaging: a shade of things to come?

CLICK FOR: SFDI biomarkers provide a quantitative ulcer risk metric and can be used to predict diabetic foot ulcer onset.

CLICK FOR: Near-instant noninvasive optical imaging of tissue perfusion for vascular assessment.

CLICK FOR: 0061U Reimbursement Information Sheet

CLICK FOR: Clarifi Brochure

CLICK FOR: Prevention of Amputation in Veterans Everywhere (PAVE) Flyer

Clarifi Imaging System

The Clarifi® Imaging System is the first non-contact, noninvasive microvascular assessment tool that uses a proprietary optical imaging technique — spatial frequency domain imaging (SFDI) — to provide insight into the delivery and extraction of oxygen to tissue.

This information can help clinicians identify patients who are at risk for vascular complications and pinpoint specific areas of potential compromised circulation before the presence of visible symptoms (e.g., ulceration).